THY1 and breast carcinoma: We have previously observed that EpCAM+ CD44+ CD90+ breast carcinoma cells in a metastatic pleural effusion survived preferentially after palliative chemotherapy.20 It is therefore of great importance to determine whether this same phenotypic population, when isolated from the blood, is tumorigenic.